Recent studies from our laboratory and others have suggested an additional role for TFR2 in response to iron-restricted erythropoiesis. These studies used mouse models with perturbed systemic iron metabolism: anemic mice lacking matriptase-2 and Tfr2, or bone marrow transplants from iron-loaded Tfr2 null mice were used. We developed a novel transgenic mouse model which lacks Tfr2 in the hematopoietic compartment, enabling the delineation of the role of Tfr2 in erythroid development without interfering with its role in systemic iron metabolism. We show that in the absence of hematopoietic Tfr2 immature polychromatic erythroblasts accumulate with a concordant reduction in the percentage of mature erythroid cells in the spleen and bone marrow of anemic mice. These results demonstrate that erythroid Tfr2 is essential for an appropriate erythropoietic response in iron-deficient anemia. These findings may be of relevance in clinical situations in which an immediate and efficient erythropoietic response is required.
Introduction
In order to maintain a steady supply of erythrocytes, most of the iron absorbed in the body is utilized in the production of hemoglobin. The recycling of iron from senescent erythrocytes is also a major contributor to the body iron needs [1] , thus creating an important bridge between iron metabolism and erythropoiesis.
Erythropoiesis itself is a known negative regulator of the iron regulatory hormone hepcidin (Hamp) [2, 3] . Although the exact molecular details of this regulation are not well understood, it is believed that the erythroid compartment releases a soluble factor which limits the production of Hamp in the liver [4] . Several candidate regulators including growth differentiation factor 15 (GDF15), twisted gastrulation 1 (TWSG1) and more recently erythroferrone (ERFE) have been reported [4] [5] [6] .
Stress such as iron deficiency stimulates the erythroid compartment in the bone marrow (BM) and this usually spills over to extramedullary sites such as the spleen and liver. An efficient erythropoietic response in conditions such as iron-deficiency anemia is essential for a proper recovery from conditions which impair oxygen delivery to the tissues, including cardiac and pulmonary syndromes, chronic anemic conditions (resulting from dietary iron deficiency or chronic disease), blood loss and therapeutic procedures such as chemotherapy and transplantation [7] , whereas an inappropriate activation of this pathway has been associated with predisposition to leukemic transformation [8] .
Transferrin receptor 2 (TFR2) is involved in the regulation of iron metabolism; patients and mice harboring TFR2 mutations develop type III hereditary hemochromatosis, characterized by inappropriate hepcidin expression relative to body iron levels [9] [10] [11] [12] . Analysis of mice with a hepatocyte-specific deletion of Tfr2 4 demonstrated the importance of hepatic TFR2 in iron metabolism [13] , as they develop similar iron overload as the Tfr2 total knockout mice.
In addition to the liver, Tfr2 expression was also detected in the bone marrow and early erythroid progenitors [14] with expression decreasing with cell differentiation [14] . Real-time PCR analysis revealed that Tfr2 expression begins between day 8 and 11 of embryonic development, which coincides with the time when primary hematopoietic cells move from the yolk sac to the liver for initial hematopoiesis [15] .
These observations are suggestive of a relation between TFR2 and erythropoiesis.
This concept is also supported by recent genome wide association studies (GWAS) which found an association between TFR2 and various hematological parameters [16] [17] [18] [19] . In one GWAS, an association was found between red blood cell (RBC) number and a SNP centered on the TFR2 gene [16] , although the authors did mention that another candidate for this association could be erythropoietin (EPO) [16, 18] . There was also a strong correlation between the hemoglobin content, hematocrit, mean cell volume and the TFR2-EPO locus in another study [17] . More recently a low frequency 5' donor splice variant of TFR2 was independently associated with higher hematocrit levels and hemoglobin concentration [19] .
It has been suggested that TFR2 can form a complex with EPOR in the UT7 cell line (endogenous protein) and transfected HEK293 cells [20] . The complex could be detected even after treatment with Brefeldin A, suggesting that the complex is formed in the early stages, probably in the endoplasmic reticulum [20] . The expression of TFR2 in HEK293 cells appeared to increase the surface localization of the erythropoietin receptor (EPOR), indicating that TFR2 could be involved in trafficking of the EPOR. Erythroid progenitors from 4-week-old TfR2 -/-mice had reduced colony-forming ability in the presence of physiological concentrations of EPO, suggesting that TFR2 is required for the differentiation of erythroid progenitors [20] . The results of these experiments suggested that TFR2 is required for the proper differentiation of erythroid cells.
Recent studies using transgenic mice lacking Tmprss6 and Hfe or Tfr2 [21, 22] 
or
Tmprss6, Hfe and Tfr2 [23] have suggested a role for Tfr2 in iron-restricted anemia.
Although the results from these studies suggested an erythroid function for Tfr2, this function could not be directly attributed to hematopoietic Tfr2 expression, as all the studies used total Tfr2 knockout (KO) mice. Using bone marrow transplant experiments to limit Tfr2 in the hematopoietic compartment of wild-type mice, it has been recently suggested that Tfr2 is required for the regulation of red blood cell production [24] .
We hypothesized that TFR2 expression in the erythroid compartment is essential for erythropoiesis in iron-deficiency induced anemia. In order to test this, we generated mice lacking Tfr2 in the erythroid compartment by crossing [25] . Only mice generated from Cre +/-male mice were used; the progeny of the females with the Cre allele were discarded as suggested [25, 26] . Control and knockout mice were fed a control (iron content: 68 mg/Kg) or an iron-deficient (ID) (iron content: 2-10 mg/Kg) diet (Specialty Feeds, Glen Forest, Western Australia) from birth. All mice were on a C57BL/6J
background.
Hematological parameters, tissue and serum iron indices
Whole blood analysis, serum iron indices, splenic (SIC) and hepatic (HIC) iron concentrations were measured as described [23, 27] .
Histology
Formalin (10%) fixed tissues were processed, paraffin embedded, sectioned and H&E staining was performed at the QIMRB Histotechnology Facility. Perls' staining was performed as described [28] . Slides were scanned and analyzed using the Aperio Scanscope XT and software (Aperio, Vista, CA) (Aperio). 
Flow cytometric analyses and cell sorting
BM cells and splenocytes were isolated by passing through a 40 µm cell strainer into or sorted into five different populations as described previously [29] . The data plots and graphs were generated using the FlowJo software package (Tree Star Inc., Ashland, OR). The sorted cells were centrifuged at 10,000 rpm for 5 minutes and resuspended in TRIzol for RNA extraction.
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Statistical Analyses
Statistical analysis on the variables between different groups of mice was performed by using two-way analysis of variance (ANOVA). Post-hoc analysis was performed to compare the differences between individual groups using Tukey's multiple comparison tests. P-values <0.05 were considered to be statistically significant.
Statistical analysis was performed using the GRAPHPAD PRISM 6 software (GraphPad Software, San Diego, CA).
Results

Tfr2 ∆/f /Vav-Cre +/-animals have reduced Tfr2 expression in the bone marrow
The control animals used for this study were heterozygous for the deleted and floxed Tfr2 alleles.This was done to avoid potential issues due to germ-line transmission of the Vav-Cre +/-allele, as previously reported [25] . Previous studies have shown that haplo-insufficiency of TFR2 does not alter systemic iron metabolism and a single allele in the heterozygous animals is sufficient to maintain appropriate iron levels [11, 12] . It has been suggested that the Vav-Cre allele could be expressed in the ovaries, hence increasing the chance of germ-line transmission through the females [25, 26] .
In view of this, only mice generated from a breeding between a Cre +/-male were used for the analyses performed in this study.
Quantitative real-time PCR (qRT-PCR) shows that the KO mice have virtually no expression of Tfr2 mRNA in the BM ( Figure 1A ) as compared to the control mice.
There were no differences in the Tfr2 levels in the spleens of the control and KO mice ( Figure 1B) . The mice fed an ID diet had less Tfr2 in the spleens ( Figure 1B ) as compared to the mice on a control diet but this was not significant. Interestingly, the livers of the KO mice had significantly lower Tfr2 levels as compared to the control mice ( Figure 1C ). Potentially this reduced hepatic Tfr2 expression could result in increased iron levels in the KO mice which could affect erythropoiesis and hence the interpretations of the study. Thus, we first examined the effects on iron indices in these mice.
Loss of hematopoietic Tfr2 does not affect systemic iron homeostasis
In order to determine whether the loss of hematopoietic Tfr2 and a reduction of hepatic Tfr2 in the KO mice alters systemic iron metabolism, we measured HIC and SIC, as well as total serum iron and transferrin saturation. Figure 1D shows that there were no significant differences in the HIC, SIC, serum iron and transferrin saturation of the KO and control mice on similar diets. As expected the iron indices (HIC, SIC, total serum iron and transferrin saturation) for the mice fed an ID diet were significantly lower as compared to the mice fed a control diet.
In addition, we determined the localization of iron in the livers of KO and control animals by Perls' staining. As seen in supplementary figure 1A , no visible differences in iron deposition in the livers of the KO and control mice was observed. These results indicated appropriate systemic iron regulation in mice even with a heterozygous deletion of Tfr2, as described previously [11, 12] . figure 2C) were similar in the control and KO mice, while the KO mice had slightly lower basal levels of hepatic Hamp as compared to the control mice, but this difference was not significant (Supplementary figure 2B) ; and as seen in Figure 1D and Supplementary figure 2A it does not affect the overall systemic regulation of iron homeostasis.
KO mice fed an ID diet show splenomegaly and extramedullary hematopoiesis in the spleen and the liver.
The control and KO mice fed an ID diet had significantly enlarged spleens as compared to the animals fed a control diet (Supplementary figure 3A) . Moreover, the KO mice fed an ID diet had larger spleens as compared to their control counterpart littermates (Supplementary figure 3A) . Splenomegaly is indicative of extramedullary hematopoiesis (EMH).
Various hematological parameters were also measured using whole blood from We examined the EMH phenotype by qRT-PCR analysis of the genes involved in erythropoiesis on RNA isolated from the BM (Figure 2A ), spleen ( Figure 2B ) and liver ( Figure 2C ) of control and KO animals. Relative levels of aminolevulinic acid synthase 2 (Alas2), glycophorin A (Gypa), hydroxymethylbilane synthase (Hmbs), and transferrin receptor 1 (Tfr1) were measured.
Although qRT-PCR analysis of the BM did not reveal any significant increases in the expression of the genes involved in erythropoiesis, there was a general increasing trend in the KO mice fed an ID diet (Figure 2A) , except for Tfr1 which exhibited a downward trend. Figure 2B shows that the relative levels of Alas2, Gypa, Hmbs and Tfr1 were significantly increased in the spleens of the KO mice fed an ID diet as compared to mice fed a control diet. These results indicate increased erythropoietic activity in the spleen. Similarly, the levels of Alas2, Hmbs and Tfr1 were significantly increased in the livers of the KO mice fed an ID diet and Gypa showed an increasing trend. These results suggest increased EMH in the livers of the KO mice fed an ID diet ( Figure 2C ).
Accumulation of immature erythroid cells in the bone marrow and spleen of KO mice fed an ID diet
We further examined the EMH phenotype in the spleens and BM of KO mice on an ID diet by performing flow cytometric analysis on splenocytes and BM cells. The cells were stained with TER119, an erythroid marker, and CD44, another cell surface marker used for separating differentiating erythroblasts into their five stages of development [29] . An analysis of erythroid cells (TER119-positive cells) revealed that both the BM and spleen of the KO mice fed an ID diet had significantly increased numbers of immature erythroid cells (Bottom right panels in Figure 3A & 3B), particularly in population III, which predominantly represents the polychromatic erythroblasts [29] .
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The percentage of erythroid cells that were polychromatic erythroblasts was significantly increased in the spleen and the BM of the KO mice fed an ID diet, suggesting that there was a developmental block in erythropoiesis in the KO mice as shown in Figure 3C and D. There was also a significant reduction in the percentage of mature erythroid cells in population V (predominantly RBCs and reticulocytes [29] in the BM and spleens of KO mice fed an ID diet ( Figure 3C & 3D) . These results are in agreement with previous studies that suggested a loss of TFR2 results in a delay in the differentiation of erythroblasts [20, 23] .
We also examined the expression of Epor, Fam132b, Tfr1 and Tfr2 using RNA extracted from the four different populations of erythroid cells isolated from the BM ( Figure 4A ) and spleen ( Figure 4B ) of the control and KO mice fed an ID diet.
Although we isolated all five populations of the erythroid cells, we could only use populations II-V for further analysis due to the quality of the RNA.
The mRNA levels of Tfr1 and Epor were significantly higher in population 3 in the KO mice in both the BM and spleen. Fam132b expression levels were also increased in all the populations of the mice fed an ID diet, although this increase was not significant. These results indicate an increase in the erythropoietic drive in the KO mice fed an ID diet supporting the hypothesis that Tfr2 is required for a proper erythropoietic response in iron-deficiency anemia.
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Discussion
Previous studies have suggested that TFR2 is expressed in erythroid cells [14] and is regulated by erythroid-specific transcription factors in vivo [15] . GWAS have suggested a correlation between the TFR2 genomic region and various hematological traits [16] [17] [18] [19] . Recent studies using mouse models of anemia have suggested that loss of Tfr2 in the erythroid compartment could be responsible for either increased RBC counts [21, 22, 24] or a block in the development of erythroblasts [23] . TFR2 was shown to be required for the proper localization and trafficking of EPOR to the surface in an erythroleukemic cell line [20] . These results taken together suggest that TFR2 has a role in erythropoiesis.
We examined the role of TFR2 in erythroid cells by generating a hematopoieticspecific knock-out model of TFR2 using Vav-Cre +/-mice on a C57BL/6J background.
The mice used for this study were heterozygous for the floxed and knockout allele for TfR2, as previously suggested [26] . This was done to avoid the germ-line transmission of a Tfr2-deleted allele that has been previously reported to occur when using the Vav-Cre transgene [25] .
Even though there was a reduction in the levels of Tfr2 in the livers of the KO mice ( Figure 1C) , it did not affect the body iron status, as the iron indices ( Figure 1D ) were not significantly different between the two genotypes fed the same diet. These results indicated that the model did not have any abnormalities in systemic iron homeostasis and was suitable for examining the role of Tfr2 specifically in the erythroid compartment.
It has been suggested that the erythropoietic function of TFR2 is evident only in ironrestricted conditions such as anemia, where anemic mice lacking Tfr2 had altered phenotypes [21] [22] [23] . In the previous studies anemia was achieved by disruption of the Tmprss6 gene, leading to enhanced hepcidin expression in the liver and hence a reduction in iron levels. In the present study, in order to establish anemic conditions, the mice were fed an ID diet for 10 weeks from birth. The hematological parameters in these mice indicated anemia, compared to the mice fed a control diet (Supplementary figure 3) . Although the Hb, MCV and RBC numbers were lower in the KO mice fed an ID diet, there were no significant differences in the hematological parameters between the KO and the control mice fed an ID diet.
One of the observations made while sacrificing the animals was that the spleens of the anemic mice were enlarged (splenomegaly) (Supplementary figure 3A) . This was 
/Tfr2
-/-mice had splenomegaly and EMH in the spleen, but the liver sections of these animals appeared normal [23] . This could be due to differences in the two anemic models, where the previous model was anemic due to a genetic mutation and the model used in this study is based on dietary anemia.
qRT-PCR analysis of the genes involved in erythropoiesis confirmed that there was increased expression of erythropoietic genes in the mice fed an ID diet and those expression levels were significantly higher in both the spleen and liver of the KO compared to control mice fed an ID diet ( Figure 2B and C) . The relative expression of erythropoietic genes was higher in the BM of the KO mice fed an ID diet but did not reach statistical significance (Figure 2A ). Flow cytometric analysis of the erythroid cells from the spleen and BM revealed that there was a significant increase in immature erythroid cells of a specific cell population (polychromatic erythroblasts) and a significant decrease in the mature cells in the anemic KO mice (Figure 3 ). Previous studies had suggested a role for Tfr2 in erythropoiesis based on the assumption that the absence of Tfr2 in the erythroid compartment was responsible for the phenotype observed but the models used in those studies lacked Tfr2 in all other tissues as well [22 , 23] . In this study the deletion is shown to be in the BM cells and the phenotype can be attributed to the lack of TFR2 specifically in the hematopoietic cells, as it has not been previously reported that mice lacking Tfr2 in the hepatocytes have abnormalities in hematological parameters or splenomegaly [13, 22] . Results published by our laboratory using a different model of anemia where the anemic mice lacking Tfr2 had splenomegaly and EMH, have also suggested a role for Tfr2 in iron-restricted erythropoiesis [23] . There are a few differences in the two models; firstly the anemia in the KO mice used for this study was dietary anemia, in contrast to the iron refractory iron deficiency anemia in the
Tmprss6
-/-mice. Secondly, the Tmprss6 -/-also developed alopecia (loss of hair) whereas the KO mice fed an ID diet did not. The KO mice in this study did not have high Hamp levels, in contrast to the Tmprss6 -/-/Tfr2 -/-mice which did [23] .
The results of our study are also different from Nai et al [24] . We observed a decrease in RBC number, whereas in their model, Nai et al observed an increase.
The anemic mice in their study did not develop splenomegaly, indicating that the degree of anemia was mild. The differences in the two studies may be explained on the basis of the mouse models used. Nai et al injected WT mice with BM transplants from Tfr2 KO mice. It has been shown that Tfr2 KO mice have significant iron overload which predisposes their BM cells to higher levels of iron as well. This may have resulted in the activation of alternate iron-dependent pathways in those mice.
Secondly, the mice were fed an ID diet for only 3 weeks after the transplant; this resulted in a very mild anemia as acknowledged by the authors [24] . In contrast, the mice used in our study were fed an ID diet from birth leading to severe anemia and the induction of iron-deficiency related erythropoiesis.
Our studies provide definitive evidence for a novel role for erythroid TFR2 expression in erythropoiesis. It will be important to examine whether Tfr2 has a role in other models of anemia such as β-thalassemia or the anemia of chronic disease and whether the absence of Tfr2 in the hematopoietic compartment affects the severity of disease in these models. Our findings may also be relevant to clinical scenarios such as chronic anemia or diseases where an immediate and effective erythropoietic response is required. In the absence of Tfr2 there would be a delay in the production of mature RBCs leading to other complications. Statistically significant differences (two-way ANOVA using Tukey's multiple comparison test are denoted * (p<0.05) and ** (p=0.001) compared to the control genotype.
